arrow
E

E. Gómez

Maastricht University
H指数:58
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer risks for MSH6 pathogenic variant carriers

MSH6致病性变异携带者的癌症风险

2025-11-060
PRE
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density

围绝经期风险降低性输卵管卵巢切除术的长期对骨密度的影响

2025-10-040
OA
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)

绝经前风险降低性输卵管卵巢切除术(RRSO)后未观察到动脉僵硬度增加

2025-06-010
PRE
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers

BRCA1/2种系致病性变异携带者中降低风险的输卵管卵巢切除术后发生的高级别浆液性癌

2024-11-230
PRE
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
2024-09-0112
OAAI
Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndrome
2024-05-090
PRE
Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers
2023-09-016
OAAI
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
2023-06-275
OAAI
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

BRCA1或BRCA2致病变异携带者的身高,体重指数和体重增加与乳腺癌风险的关联: BRCA1和BRCA2队列联盟

2023-06-206
OAAI
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
2023-04-012
OAAI
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study
2023-02-194
OA
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases
2022-09-2220
OA
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study

化疗对BRCA1和BRCA2突变携带者对侧乳腺癌风险的影响: 一项全国性队列研究

BREAST
IF7.9
2022-02-018
OAAI
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
2021-03-1251
OAAI
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)
2021-01-2211
OAAI
An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome
2019-12-0113
OAAI